Renal denervation for the management of resistant hypertension
Hitesh C Patel,1 Carl Hayward,1 Vassilis Vassiliou,1 Ketna Patel,2 James P Howard,3 Carlo Di Mario11NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK; 2Department of Cardiology, Royal Free Hospital, London, UK; 3National Heart and Lung Institute, Imperial College, Lon...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-12-01
|
| Series: | Integrated Blood Pressure Control |
| Subjects: | |
| Online Access: | https://www.dovepress.com/renal-denervation-for-the-management-of-resistant-hypertension-peer-reviewed-article-IBPC |
| _version_ | 1819169572124622848 |
|---|---|
| author | Patel HC Hayward C Vassiliou V Patel K Howard JP Di Mario C |
| author_facet | Patel HC Hayward C Vassiliou V Patel K Howard JP Di Mario C |
| author_sort | Patel HC |
| collection | DOAJ |
| description | Hitesh C Patel,1 Carl Hayward,1 Vassilis Vassiliou,1 Ketna Patel,2 James P Howard,3 Carlo Di Mario11NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK; 2Department of Cardiology, Royal Free Hospital, London, UK; 3National Heart and Lung Institute, Imperial College, London, UKAbstract: Renal sympathetic denervation (RSD) as a therapy for patients with resistant hypertension has attracted great interest. The majority of studies in this field have demonstrated impressive reductions in blood pressure (BP). However, these trials were not randomized or sham-controlled and hence, the findings may have been overinflated due to trial biases. SYMPLICITY HTN-3 was the first randomized controlled trial to use a blinded sham-control and ambulatory BP monitoring. A surprise to many was that this study was neutral. Possible reasons for this neutrality include the fact that RSD may not be effective at lowering BP in man, RSD was not performed adequately due to limited operator experience, patients’ adherence with their antihypertensive drugs may have changed during the trial period, and perhaps the intervention only works in certain subgroups that are yet to be identified. Future studies seeking to demonstrate efficacy of RSD should be designed as randomized blinded sham-controlled trials. The efficacy of RSD is in doubt, but many feel that its safety has been established through the thousands of patients in whom the procedure has been performed. Over 90% of these data, however, are for the Symplicity™ system and rarely extend beyond 12 months of follow-up. Long-term safety cannot be assumed with RSD and nor should it be assumed that if one catheter system is safe then all are. We hope that in the near future, with the benefit of well-designed clinical trials, the role of renal denervation in the management of hypertension will be established.Keywords: resistant hypertension, renal denervation, sympathetic nervous system, symplicity |
| first_indexed | 2024-12-22T19:21:38Z |
| format | Article |
| id | doaj.art-a502fc504b2a426db47178eca11284a1 |
| institution | Directory Open Access Journal |
| issn | 1178-7104 |
| language | English |
| last_indexed | 2024-12-22T19:21:38Z |
| publishDate | 2015-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Integrated Blood Pressure Control |
| spelling | doaj.art-a502fc504b2a426db47178eca11284a12022-12-21T18:15:21ZengDove Medical PressIntegrated Blood Pressure Control1178-71042015-12-012015Issue 1576924866Renal denervation for the management of resistant hypertensionPatel HCHayward CVassiliou VPatel KHoward JPDi Mario CHitesh C Patel,1 Carl Hayward,1 Vassilis Vassiliou,1 Ketna Patel,2 James P Howard,3 Carlo Di Mario11NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK; 2Department of Cardiology, Royal Free Hospital, London, UK; 3National Heart and Lung Institute, Imperial College, London, UKAbstract: Renal sympathetic denervation (RSD) as a therapy for patients with resistant hypertension has attracted great interest. The majority of studies in this field have demonstrated impressive reductions in blood pressure (BP). However, these trials were not randomized or sham-controlled and hence, the findings may have been overinflated due to trial biases. SYMPLICITY HTN-3 was the first randomized controlled trial to use a blinded sham-control and ambulatory BP monitoring. A surprise to many was that this study was neutral. Possible reasons for this neutrality include the fact that RSD may not be effective at lowering BP in man, RSD was not performed adequately due to limited operator experience, patients’ adherence with their antihypertensive drugs may have changed during the trial period, and perhaps the intervention only works in certain subgroups that are yet to be identified. Future studies seeking to demonstrate efficacy of RSD should be designed as randomized blinded sham-controlled trials. The efficacy of RSD is in doubt, but many feel that its safety has been established through the thousands of patients in whom the procedure has been performed. Over 90% of these data, however, are for the Symplicity™ system and rarely extend beyond 12 months of follow-up. Long-term safety cannot be assumed with RSD and nor should it be assumed that if one catheter system is safe then all are. We hope that in the near future, with the benefit of well-designed clinical trials, the role of renal denervation in the management of hypertension will be established.Keywords: resistant hypertension, renal denervation, sympathetic nervous system, symplicityhttps://www.dovepress.com/renal-denervation-for-the-management-of-resistant-hypertension-peer-reviewed-article-IBPCResistant hypertensionRenal denervationSympathetic nervous systemSymplicity |
| spellingShingle | Patel HC Hayward C Vassiliou V Patel K Howard JP Di Mario C Renal denervation for the management of resistant hypertension Integrated Blood Pressure Control Resistant hypertension Renal denervation Sympathetic nervous system Symplicity |
| title | Renal denervation for the management of resistant hypertension |
| title_full | Renal denervation for the management of resistant hypertension |
| title_fullStr | Renal denervation for the management of resistant hypertension |
| title_full_unstemmed | Renal denervation for the management of resistant hypertension |
| title_short | Renal denervation for the management of resistant hypertension |
| title_sort | renal denervation for the management of resistant hypertension |
| topic | Resistant hypertension Renal denervation Sympathetic nervous system Symplicity |
| url | https://www.dovepress.com/renal-denervation-for-the-management-of-resistant-hypertension-peer-reviewed-article-IBPC |
| work_keys_str_mv | AT patelhc renaldenervationforthemanagementofresistanthypertension AT haywardc renaldenervationforthemanagementofresistanthypertension AT vassiliouv renaldenervationforthemanagementofresistanthypertension AT patelk renaldenervationforthemanagementofresistanthypertension AT howardjp renaldenervationforthemanagementofresistanthypertension AT dimarioc renaldenervationforthemanagementofresistanthypertension |